Answers are grounded in this paper and cite their sources.
Retrospective cross-sectional study reveals elevated interstitial lung disease risk in anti-Ro52-positive primary Sjögren’s disease, highlighting its value in clinical phenotyping.
To investigate the association of anti-Ro52 antibody positivity with interstitial lung disease (ILD), serological findings, clinical manifestations, and treatment patterns in patients with primary Sjögren’s disease (SjD). This retrospective cross-sectional study included 205 patients with SjD. Patients were classified as anti-Ro52-positive or anti-Ro52-negative. Demographic features, clinical findings, laboratory variables, systemic involvement, and treatment patterns were compared between groups. Binary logistic regression analyses were performed to evaluate the independent association between anti-Ro52 positivity and ILD. Other between-group comparisons were considered exploratory and were adjusted for multiple testing using the Benjamini-Hochberg false discovery rate (FDR) procedure. Of the 205 patients, 101 (49.3%) were anti-Ro52 positive and 104 (50.7%) were anti-Ro52 negative. ILD was more frequent in anti-Ro52-positive patients than in anti-Ro52-negative patients (27.7% vs. 10.6%, p = 0.003). In univariable analysis, anti-Ro52 positivity was associated with ILD (OR 3.24, 95% CI 1.51–6.95, p = 0.002). This association remained significant after adjustment for age, sex, smoking status, and disease duration (adjusted OR 3.61, 95% CI 1.64–7.96, p = 0.001), and after further adjustment for anti-SSA positivity (adjusted OR 4.48, 95% CI 1.86–10.81, p < 0.001). Anti-Ro52-positive patients also had higher frequencies of anti-SSA positivity, anti-SSB positivity, and a speckled ANA pattern after FDR correction. Anti-Ro52 positivity was associated with a higher frequency of ILD and a distinct serological profile in SjD. These findings support its potential value in clinical phenotyping, although prospective multicenter studies are needed for validation.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: